Geron Corporation
GERN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Geron Corporation, společnost působící v pozdním stadiu klinického biofarmaceutického výzkumu, se zaměřuje na vývoj a komercializaci léků pro léčbu myeloidních hematologických malignit. Vyvíjí se imetelstat, inhibitor telomerázy, který je součástí klinických studií fáze 3 a který inhibuje nekontrolovanou proliferaci maligních kmenových a progenitorových buněk hematologických myeloidních malignit pro léčbu nízko nebo středně rizikových myelodysplastických syndromů a středně rizikové myelofibrózy 2 nebo středně vysoké riziko. Společnost byla založena v roce 1990 a sídlí ve Foster City v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
229
Založení
1996-07-31
Podobné společnosti
$ 10.02
+ $ 0.29
$ 11.24
+ $ 0.61
$ 8.71
- $ 0.02
$ 14.36
+ $ 0.04
$ 5.36
+ $ 0.23
$ 3.97
+ $ 0.02
$ 8.66
+ $ 0.35
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 183.9 | 183.9 | 77.0 | 0.2 | 0.6 | 1.4 | 0.3 | 0.5 | 1.1 | 1.1 | 6.2 | 36.4 | 1.2 | 1.3 | 2.7 | 2.4 | 3.6 | |
| Cost of Revenues | 25.8 | 4.7 | 1.3 | 123.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 158.1 | 179.1 | 75.7 | -123.5 | 0.6 | 1.4 | 0.3 | 0.5 | 1.1 | 1.1 | 6.2 | 36.4 | 1.2 | 1.3 | 2.7 | 2.4 | 3.6 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 48.0 | 47.2 | 49.0 | 39.6 | 47.5 | 28.3 | 0.9 | 0.3 | 0.0 | 0.2 | |
| Cost of Revenues | 1.3 | 22.1 | 1.2 | 1.2 | 0.8 | 0.5 | 0.0 | 0.0 | 0.2 | 29.4 | |
| Gross Profit | 46.7 | 25.1 | 47.8 | 38.4 | 46.8 | 27.8 | 0.9 | 0.3 | -0.2 | -29.3 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 125.0 | 95.5 | 85.7 | 51.5 | 52.1 | 13.4 | 11.0 | 18.0 | 17.8 | 20.7 | 23.2 | 51.4 | 69.3 | 61.7 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 69.1 | 43.6 | 29.7 | 25.7 | 20.9 | 18.7 | 19.3 | 18.8 | 17.8 | 16.8 | 15.6 | 20.4 | 23.8 | 18.0 | |
| Depreciation & Amortization | 1.0 | 1.2 | 1.2 | 1.0 | 3.5 | 2.4 | 2.0 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.8 | 1.6 | 1.6 | |
| Total Operating Expenses | 211.9 | 233.0 | 249.5 | 194.2 | 139.1 | 115.4 | 77.2 | 73.0 | 32.1 | 30.3 | 36.8 | 35.6 | 37.5 | 38.8 | 71.8 | 93.1 | 79.7 | |
| Operating Income | -53.8 | -53.8 | -173.7 | -193.9 | -138.6 | -114.0 | -76.9 | -72.5 | -31.1 | -29.3 | -30.6 | -0.6 | -36.3 | -39.0 | -71.8 | -96.1 | -111.2 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 32.9 | 29.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.2 | 18.4 | ||
| Depreciation & Amortization | 0.3 | 0.1 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.2 | 0.3 | ||
| Total Operating Expenses | 57.5 | 39.0 | 60.3 | 55.1 | 66.8 | 56.0 | 70.2 | 56.4 | 54.1 | 47.8 | ||
| Operating Income | -10.8 | -13.9 | -12.5 | -16.7 | -20.1 | -28.2 | -69.3 | -56.1 | -54.3 | -47.6 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 18.1 | 18.1 | 19.6 | 18.2 | 2.5 | 0.5 | 1.8 | 4.2 | 3.3 | 1.4 | 1.2 | 0.7 | 0.4 | 1.0 | 3.1 | 1.0 | 2.0 | |
| Interest Expense | 32.7 | 32.7 | 18.5 | 8.3 | 6.9 | 3.7 | 0.8 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | |
| Other Expense | -31.9 | -31.9 | -0.8 | 9.8 | -3.4 | -2.1 | 1.3 | 4.0 | 0.8 | 1.3 | 1.1 | -1.3 | 0.4 | -1.8 | -2.7 | -7.0 | -37.2 | |
| IBT | -85.8 | -85.8 | -174.6 | -184.1 | -141.9 | -116.1 | -75.6 | -68.5 | -27.0 | -27.9 | -29.5 | 0.0 | -35.7 | -38.4 | -68.9 | -96.9 | -111.4 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | 4.8 | 0.0 | -5.0 | 4.1 | 1.3 | 1.1 | 0.0 | 0.0 | 0.1 | -0.6 | 5.7 | 31.3 | |
| Net Income | -85.8 | -85.8 | -174.6 | -184.1 | -141.0 | -121.0 | -75.6 | -63.6 | -27.0 | -27.9 | -29.5 | 0.0 | -35.7 | -38.4 | -68.9 | -96.9 | -111.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.0 | 4.3 | 4.7 | 5.2 | 5.2 | 4.9 | 5.3 | 4.2 | 4.6 | 5.0 | ||
| Interest Expense | 7.3 | 8.6 | 8.5 | 8.2 | 8.7 | 3.0 | 3.3 | 3.4 | 2.3 | 2.1 | ||
| Other Expense | -20.4 | -4.5 | -3.9 | -3.1 | -5.3 | 1.8 | 2.0 | 0.7 | 2.3 | 2.8 | ||
| IBT | -31.1 | -18.4 | -16.4 | -19.8 | -25.4 | -26.4 | -67.4 | -55.4 | -52.0 | -44.8 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | -0.3 | ||
| Net Income | -31.1 | -18.4 | -16.4 | -19.8 | -25.4 | -26.4 | -67.4 | -55.4 | -52.0 | -44.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.32 | $-0.37 | $-0.37 | $-0.28 | $-0.33 | $-0.15 | $-0.18 | $-0.19 | $0.00 | $-0.23 | $-0.30 | $-0.54 | $-0.78 | $-1.14 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.32 | $-0.37 | $-0.37 | $-0.28 | $-0.33 | $-0.15 | $-0.18 | $-0.19 | $0.00 | $-0.23 | $-0.30 | $-0.54 | $-0.78 | $-1.14 | |
| Shares Outstanding | 667.2 | 666.7 | 646.0 | 570.6 | 380.8 | 327.6 | 271.5 | 190.2 | 176.5 | 159.2 | 159.0 | 158.0 | 153.5 | 128.4 | 126.9 | 124.5 | 97.6 | |
| Diluted Shares Outstanding | 667.2 | 666.7 | 646.0 | 570.6 | 380.8 | 327.6 | 271.5 | 190.2 | 176.5 | 159.2 | 159.0 | 162.7 | 153.5 | 128.4 | 126.9 | 124.5 | 97.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.09 | $-0.08 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.09 | $-0.08 | ||
| Shares Outstanding | 667.2 | 667.1 | 666.2 | 665.9 | 646.0 | 662.2 | 653.9 | 603.5 | 595.0 | 579.5 | ||
| Diluted Shares Outstanding | 667.2 | 667.1 | 666.2 | 665.9 | 646.0 | 662.2 | 653.9 | 603.5 | 595.0 | 579.5 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 118.1 | 79.0 | 70.0 | 57.2 | 34.9 | 10.3 | 13.9 | 10.8 | 16.6 | 13.1 | 21.5 | 43.1 | 13.0 | 22.9 | 16.1 | 46.8 | |
| Short Term Investments | 245.8 | 327.6 | 263.7 | 115.9 | 148.9 | 186.4 | 125.7 | 152.7 | 78.4 | 102.0 | 92.5 | 108.6 | 52.2 | 73.5 | 105.2 | 140.6 | |
| Total Cash & ST Investments | 363.9 | 406.6 | 333.7 | 173.1 | 183.7 | 196.6 | 139.6 | 163.6 | 95.0 | 115.1 | 114.0 | 151.7 | 65.2 | 96.3 | 121.3 | 187.4 | |
| Accounts Receivable | 3.1 | 38.8 | 1.7 | 3.1 | 1.8 | 0.7 | 0.8 | 1.2 | 0.4 | 0.5 | 1.2 | 1.0 | 0.6 | 0.8 | 1.4 | 1.8 | |
| Inventory | 0.8 | 38.7 | 0.0 | -3.1 | -1.4 | -0.7 | -0.8 | -1.2 | -0.4 | -0.5 | -1.2 | -1.0 | 0.0 | -0.8 | 0.0 | -1.8 | |
| Other Current Assets | 5.6 | 6.9 | 6.0 | 7.1 | 3.1 | 3.2 | 2.0 | 2.5 | 1.0 | 1.0 | 1.9 | 1.7 | 1.3 | 2.1 | 2.9 | 7.7 | |
| Total Current Assets | 373.3 | 491.0 | 341.3 | 180.2 | 187.2 | 199.9 | 141.6 | 166.1 | 96.0 | 116.1 | 115.9 | 153.4 | 67.1 | 98.4 | 125.6 | 195.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 78.1 | 77.7 | 83.7 | 79.0 | 60.3 | 116.9 | 189.8 | 71.1 | 30.7 | 56.9 | |
| Short Term Investments | 302.4 | 310.2 | 313.1 | 327.6 | 279.4 | 245.8 | 253.3 | 263.7 | 282.8 | 314.5 | |
| Total Cash & ST Investments | 380.5 | 388.0 | 396.9 | 406.6 | 339.8 | 362.7 | 443.0 | 334.8 | 313.5 | 371.4 | |
| Accounts Receivable | 35.4 | 39.4 | 34.0 | 38.8 | 30.1 | 3.1 | 1.6 | 1.7 | 14.8 | 1.2 | |
| Inventory | 95.4 | 69.1 | 56.2 | 38.7 | 20.3 | 0.8 | 0.0 | 0.0 | 0.5 | 0.5 | |
| Other Current Assets | 11.0 | 9.1 | 8.7 | 6.9 | 7.9 | 6.7 | 6.8 | 4.9 | 6.8 | 4.7 | |
| Total Current Assets | 522.3 | 505.6 | 495.8 | 491.0 | 398.1 | 373.3 | 451.5 | 341.3 | 335.1 | 377.3 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 4.9 | 4.2 | 4.7 | 0.8 | 5.4 | 0.7 | 0.4 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 1.0 | 1.2 | 3.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 66.5 | 94.5 | 43.3 | 0.0 | 28.7 | 63.4 | 19.7 | 18.6 | 14.2 | 14.0 | 32.7 | 18.9 | 0.0 | 0.0 | 32.1 | 33.9 | |
| Other Long-Term Assets | 4.7 | 4.1 | 4.7 | 9.5 | 4.8 | 6.8 | 3.9 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.4 | 1.0 | 1.6 | |
| Total Long-Term Assets | 76.1 | 102.8 | 52.7 | 10.3 | 38.8 | 70.9 | 23.9 | 19.2 | 14.3 | 14.1 | 32.9 | 19.1 | 0.3 | 1.4 | 34.4 | 38.6 | |
| Total Assets | 449.4 | 593.8 | 394.1 | 190.6 | 226.0 | 270.7 | 165.5 | 185.3 | 110.3 | 130.2 | 148.8 | 172.5 | 67.3 | 99.8 | 160.0 | 233.6 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.3 | 3.7 | 3.9 | 4.2 | 4.7 | 4.9 | 5.1 | 4.7 | 4.9 | 5.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 39.1 | 42.7 | 58.8 | 94.5 | 37.3 | 66.5 | 20.8 | 43.3 | 67.8 | 28.3 | |
| Other Long-Term Assets | 2.7 | 3.1 | 4.0 | 4.1 | 4.9 | 4.7 | 4.7 | 4.7 | 5.2 | 4.7 | |
| Total Long-Term Assets | 45.0 | 49.6 | 66.7 | 102.8 | 46.9 | 76.1 | 30.6 | 52.7 | 77.9 | 38.0 | |
| Total Assets | 567.4 | 555.2 | 562.5 | 593.8 | 445.0 | 449.4 | 482.1 | 394.1 | 413.0 | 415.3 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.6 | 8.6 | 6.2 | 10.2 | 6.7 | 6.9 | 1.2 | 1.0 | 0.5 | 0.2 | 0.2 | 1.0 | 1.4 | 3.4 | 3.0 | 3.5 | |
| Short-Term Debt | 47.9 | 1.0 | 47.8 | 21.9 | 0.9 | 0.9 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 5.8 | 0.0 | 0.0 | 0.0 | 8.8 | |
| Other Current Liabilities | 50.0 | 78.7 | 54.1 | 44.6 | 37.9 | 23.1 | 26.6 | 6.6 | 6.0 | 7.6 | 6.5 | 0.0 | 6.2 | 10.7 | 10.5 | 28.2 | |
| Current Liabilities | 103.5 | 88.3 | 108.1 | 76.7 | 45.5 | 30.9 | 28.2 | 7.6 | 6.5 | 7.9 | 6.6 | 41.8 | 7.6 | 14.1 | 13.4 | 40.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 11.1 | 8.2 | 8.0 | 8.6 | 13.7 | 5.6 | 10.0 | 6.2 | 13.7 | 7.7 | |
| Short-Term Debt | 1.0 | 1.0 | 1.0 | 1.0 | 72.5 | 47.9 | 72.5 | 47.8 | 23.0 | 11.6 | |
| Other Current Liabilities | 75.6 | 55.1 | 53.1 | 78.7 | 51.7 | 50.0 | 40.7 | 54.1 | 52.7 | 53.3 | |
| Current Liabilities | 87.7 | 64.3 | 63.0 | 88.3 | 137.9 | 103.5 | 123.2 | 108.1 | 89.4 | 72.6 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 36.5 | 120.7 | 38.1 | 33.9 | 54.1 | 28.8 | 2.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 2.6 | 3.2 | 4.0 | 4.6 | 5.2 | 5.7 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 142.7 | 313.5 | 146.1 | 110.6 | 99.6 | 59.8 | 30.4 | 7.6 | 6.5 | 7.9 | 6.6 | 41.8 | 7.6 | 14.1 | 13.4 | 40.8 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 120.9 | 120.9 | 120.8 | 120.7 | 14.7 | 39.2 | 14.0 | 38.1 | 33.0 | 44.3 | |
| Capital Leases | 2.7 | 2.9 | 3.1 | 3.2 | 3.4 | 3.6 | 3.8 | 3.0 | 4.1 | 4.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 318.7 | 295.7 | 294.2 | 313.5 | 152.7 | 142.7 | 137.2 | 146.1 | 122.4 | 116.9 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -1,720.5 | -1,772.3 | -1,597.8 | -1,413.6 | -1,271.7 | -1,155.6 | -1,080.0 | -1,011.5 | -985.8 | -957.9 | -928.4 | -928.4 | -892.8 | -854.4 | -785.5 | -688.7 | |
| Comprehensive Income | -0.5 | 0.3 | 0.2 | -0.2 | -0.2 | 0.1 | 0.1 | -0.2 | -0.2 | -0.1 | -0.2 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | |
| Total Common Equity | 306.7 | 280.3 | 247.9 | 80.0 | 126.4 | 210.9 | 135.2 | 177.7 | 103.8 | 122.4 | 142.1 | 130.7 | 59.8 | 85.7 | 146.6 | 192.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | |
| Retained Earnings | -1,827.0 | -1,808.6 | -1,792.2 | -1,772.3 | -1,747.0 | -1,720.5 | -1,653.2 | -1,597.8 | -1,545.8 | -1,501.0 | |
| Comprehensive Income | 0.4 | 0.1 | 0.3 | 0.3 | 1.0 | -0.5 | -0.3 | 0.2 | -1.0 | -0.9 | |
| Total Common Equity | 248.7 | 259.5 | 268.2 | 280.3 | 292.3 | 306.7 | 344.9 | 247.9 | 290.6 | 298.4 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 87.0 | 121.7 | 85.9 | 55.8 | 55.0 | 29.7 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 306.7 | 280.3 | 247.9 | 80.0 | 126.4 | 210.9 | 135.2 | 177.7 | 103.8 | 122.4 | 142.1 | 130.7 | 59.8 | 85.7 | 146.6 | 192.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 248.7 | 259.5 | 268.2 | 280.3 | 292.3 | 306.7 | 344.9 | 247.9 | 290.6 | 298.4 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -219.6 | -85.8 | -174.6 | -184.1 | -141.9 | -116.1 | -75.6 | -68.5 | -27.0 | -27.9 | -29.5 | 0.0 | -35.7 | -38.4 | -68.9 | -96.9 | -111.4 | |
| Depreciation & Amortization | 1.2 | 1.2 | 1.2 | 1.0 | 0.9 | 0.8 | 0.9 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | 0.8 | 1.6 | 1.6 | |
| Stock-Based Compensation | 29.1 | 0.1 | 31.3 | 19.4 | 8.0 | 8.1 | 6.9 | 6.1 | 6.4 | 8.1 | 8.2 | 8.4 | 7.7 | 4.4 | 5.3 | 15.2 | 13.7 | |
| Change Working Capital | -9.4 | -68.5 | -68.4 | 6.1 | 5.0 | 10.5 | 0.4 | 19.1 | -0.2 | -1.4 | 2.1 | -35.3 | 34.4 | -4.8 | 4.4 | 8.7 | 9.1 | |
| Change In Accounts Receivable | 0.0 | -0.4 | -36.9 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 0.0 | 2.7 | 2.4 | -4.0 | 3.5 | -0.2 | 5.7 | 0.2 | 0.5 | 0.3 | 0.1 | -0.9 | -0.4 | -2.0 | 0.4 | -0.5 | 1.3 | |
| Change In Inventories | 0.0 | -77.9 | -38.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 18.9 | 42.0 | -8.2 | -10.1 | 0.6 | 1.0 | 0.3 | 0.1 | 0.2 | 0.2 | 0.2 | 0.4 | 0.3 | 0.3 | 0.2 | 0.0 | 27.3 | |
| Cash from Operations | -206.9 | 0.0 | 0.0 | -167.7 | -127.4 | -95.6 | -66.7 | -43.8 | -21.0 | -20.6 | -18.4 | -24.2 | 9.4 | -36.7 | -55.1 | -62.4 | -44.3 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -28.9 | -18.4 | -16.4 | -19.8 | -25.4 | -26.4 | -67.4 | -55.4 | -52.0 | -44.8 | |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.2 | 0.3 | |
| Stock-Based Compensation | 7.4 | 6.8 | -7.4 | 7.4 | 6.8 | 0.0 | 12.6 | 5.0 | 4.4 | 7.2 | |
| Change Working Capital | -12.5 | -2.3 | -18.6 | -35.2 | -22.9 | -37.6 | 2.7 | -10.5 | 9.3 | -10.8 | |
| Change In Accounts Receivable | -1.0 | 1.3 | -5.3 | 4.6 | -8.9 | -27.1 | -0.9 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | -21.2 | -26.3 | -12.9 | -17.5 | -17.7 | -19.5 | -0.8 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 11.6 | 0.1 | 14.6 | -0.7 | -2.8 | 4.9 | -1.8 | -1.6 | 2.6 | 0.7 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -40.3 | -50.8 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.1 | 0.0 | -0.7 | -0.8 | -0.4 | -0.2 | -0.4 | -0.4 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | 0.0 | -0.9 | -0.6 | -0.8 | |
| Acquisitions | -43.1 | 0.0 | 0.0 | 179.5 | -1.2 | 1.6 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.2 | 0.2 | 0.0 | 0.0 | |
| Investments | -346.2 | -304.4 | -476.9 | -475.6 | -258.0 | -177.4 | -313.2 | -153.5 | -188.4 | -100.0 | -129.3 | -206.5 | -190.3 | -89.0 | -79.4 | -144.9 | -183.4 | |
| Sales of Investment | 388.2 | 411.7 | 371.6 | 296.1 | 320.5 | 249.6 | 208.3 | 181.3 | 110.7 | 123.0 | 138.1 | 206.6 | 112.0 | 108.8 | 141.0 | 177.6 | 137.3 | |
| Other Investing Activities | 77.9 | 0.0 | 0.0 | -179.5 | 1.2 | -1.6 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | -1.5 | |
| Cash from Investing | 40.9 | 0.0 | 0.0 | -180.3 | 62.1 | 71.9 | -105.3 | 27.4 | -77.7 | 23.0 | 8.8 | 0.1 | -77.9 | 21.1 | 61.0 | 32.1 | -48.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | 0.1 | -0.1 | 0.0 | 0.1 | 0.0 | -0.2 | -0.6 | -0.1 | -0.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -47.6 | 4.5 | |
| Investments | -104.2 | -77.0 | -76.7 | -46.5 | -184.8 | -65.8 | -160.7 | -65.6 | -15.9 | -104.0 | |
| Sales of Investment | 125.4 | 90.3 | 97.2 | 98.9 | 81.1 | 65.3 | 124.8 | 100.4 | 63.5 | 99.5 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 47.6 | -4.5 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 47.6 | -4.7 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -29.1 | 0.0 | 0.0 | 29.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.4 | 0.0 | |
| Debt Issued | 60.2 | 121.7 | 35.8 | 59.8 | 0.8 | 25.3 | 27.2 | 2.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.4 | 0.0 | |
| Issuance of Common Stock | 197.6 | 0.0 | 0.0 | 213.3 | 69.9 | 20.4 | 144.3 | 19.3 | 86.0 | 1.1 | 1.2 | 2.6 | 98.4 | 6.6 | 0.2 | 0.4 | 104.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 228.5 | 0.0 | 0.0 | 119.0 | 17.3 | 28.2 | 24.1 | 0.2 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.4 | 0.0 | |
| Cash from Financing | 226.6 | 0.0 | 0.0 | 362.0 | 87.3 | 48.6 | 168.3 | 19.5 | 93.0 | 1.1 | 1.2 | 2.6 | 98.4 | 6.6 | 0.2 | 0.4 | 104.1 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 121.9 | 0.1 | 0.1 | 0.1 | 34.5 | 0.2 | 0.5 | 0.6 | 29.9 | 0.1 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 29.4 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 33.3 | 29.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 32.6 | 29.4 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 60.6 | -1.4 | 9.7 | 13.9 | 22.0 | 24.9 | -3.6 | 3.1 | -5.8 | 3.5 | -8.4 | -21.5 | 29.8 | -9.1 | 6.0 | -29.9 | 11.4 | |
| Closing Cash Balance | 118.1 | 79.4 | 80.9 | 71.1 | 57.2 | 35.2 | 10.3 | 13.9 | 10.8 | 16.3 | 12.8 | 21.2 | 42.8 | 13.0 | 22.1 | 16.1 | 46.0 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -0.6 | 0.4 | -6.0 | 4.7 | 18.7 | -55.9 | -72.8 | 119.7 | 39.9 | -26.2 | |
| Closing Cash Balance | 79.4 | 80.0 | 79.6 | 85.6 | 80.9 | 62.2 | 118.1 | 190.9 | 71.1 | 31.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -207.9 | -111.1 | -219.3 | -168.6 | -127.8 | -95.8 | -67.1 | -44.2 | -21.0 | -20.6 | -18.4 | -24.3 | 9.2 | -36.7 | -56.0 | -63.0 | -45.1 | |
| Real Free Cash Flow | -237.1 | -111.2 | -250.6 | -187.9 | -135.8 | -103.8 | -73.9 | -50.3 | -27.4 | -28.7 | -26.7 | -32.7 | 1.6 | -41.1 | -61.3 | -78.3 | -58.8 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -22.1 | -13.5 | -27.6 | -48.0 | -43.8 | -58.9 | -53.7 | -62.9 | -40.4 | -51.0 | |
| Real Free Cash Flow | -29.5 | -20.3 | -20.2 | -55.4 | -50.6 | -58.9 | -66.3 | -67.8 | -44.8 | -58.2 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -11.4 | 130.3 | -1.4 |
| P/S | 5.3 | 614.9 | 9.4 |
| P/B | 3.9 | 3.8 | 5.2 |
| P/FCF | -7.8 | 17.1 | -1.5 |
| Market cap | $0.7 | $3.2 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 21.5 % | 6 % | 0 % |
| Debt to Income | -142.1 % | -17 % | 0 % |
| Debt to Free cash flow | -97.3 % | -634.3 % | 0 % |
| Interest expense percentage | -60.7 % | -3.6 % | 44.7 % |
| Current ratio | 6 | 12 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -34.5 % | -48.1 % | 0 % |
| ROA | -15.1 % | -36.5 % | 0 % |
| CapEx to Revenue | -0.1 % | 43.7 % | 0 % |
| RaD to Revenue | 0 % | 6526.2 % | 0 % |
| ROEM | 802,973.8 | 171102.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 86.2 % | -414.3 % | 68.7 % |
| Operating margin | -34.4 % | -9891.8 % | 35.5 % |
| Net margin | -43.6 % | -9645.2 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 667.1 mil | 258.5 mil |
| Employee count | 0.2 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
